SuperworthPark Dental Partners EPS PARK
Diluted earnings per share by quarter and over the last twelve months, from 2025.
- Last 12 months, to Jun 30, 2026
- n/m
- a quarter missing
- Latest quarter, Q2 FY26
- $0.22
- −85% on a year earlier
Park Dental Partners' twelve-month earnings per share can't be added up yet: a quarter of its results is missing from our data.
In its latest quarter, Q2 FY26, it was $0.22, down 85% on the same quarter a year before.
Earnings per share over time
Quarter by quarter
| Quarter | Ended | EPS | On a year earlier |
|---|---|---|---|
| Q2 FY26 | $0.22 | −85% | |
| Q1 FY26 | −$0.09 | −110% | |
| Q2 FY25 | $1.45 | n/a | |
| Q1 FY25 | $0.88 | n/a |
Against its peers
Companies in Healthcare nearest Park Dental Partners' size, closest first, today.
| Company | EPS, 12 months | Growth |
|---|---|---|
| PARKPark Dental Partners | n/m | |
| KEQUKewaunee Scientific | $2.76 | −33% a year |
| ICCCImmucell | $0.08 | −58% a year |
| LFVNLifevantage | $0.40 | −46% a year |
| SPROSpero Therapeutics | $0.11 | |
| APTAlpha Pro Tech | $0.41 | +24% a year |
| ATNMActinium Pharmaceuticals | $0.36 | |
| PDEXPro DEX | $4.11 | +52% a year |
| PLXProtalix BioTherapeutics | $0.23 | +283% a year |
| NATRNatures Sunshine Products | $1.01 | +36% a year |
| ELMDElectromed | $1.31 | +56% a year |
| Peer median | $0.41 |
What the EPS figure tells you
Net income divided by diluted shares. The denominator of PE.
One-off charges and gains swing it. The TTM view smooths a single odd quarter.
More on Park Dental Partners
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.